Good News for Brittle Bone sufferers
Osteogenesis Imperfecta (OI) also known as brittle bone disease is a genetic disorder affecting up to 1 in 15,000 people in the UK. Children suffering from the disease are often born with fractures that have occurred in the womb. Fractures can also occur shortly after birth even without any obvious bump or trauma.
The University of Sheffield and Sheffield Children’s Hospital have developed an exciting new treatment for children suffering from OI. They have identified that the risk of fractures is reduced by using the medicine Risedronate. Why is this development so important for the children and their families? This medicine can be taken orally in their home. So it not only reduces visits to hospital for treatment of fractures, but their routine visits for their medication. By reducing their many trips to hospital for treatment, the children have more time to attend school and lead as normal a life as possible, which is excellent news for young OI sufferers who have to deal with this devastating condition.
For further information on the subject see http://www.brittlebone.org/about-o.i.html